Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genetracer Biotech
Santander, Cantabria, Spaininfoempresa.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Genetracer Biotech is a Spanish precision medicine company specializing in early cancer detection and recurrence monitoring using advanced liquid biopsy techniques. Their DECODER platform enables noninvasive blood-based enrichment of CTCs and ctDNA, supporting real-time tracking of tumor mutations. The company has also developed digital solutions for COVID status tracking during the pandemic[1][5][6].
- Therapeutic areas
- Oncology
- Modalities
- Liquid biopsyNext Generation Sequencing (NGS)Genetic testing (blood-based)
- Industry
- Molecular Diagnostics
02
Partnerships
Fluxion Biosciences – certified service provider partnership for IsoFlux CTC Liquid Biopsy System[5]
Beyond the preview
Go deeper on Genetracer Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genetracer Biotech.